---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-059372"
form_type: "8-K"
ticker: "HSDT"
cik: "0001610853"
company_name: "Solana Co"
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:05:01.977500+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Helius Medical prices $6.4M public offering of stock and warrants

## Summary
- Offering consists of 804,999 shares, 2,047,222 pre-funded warrants, and Series A/B warrants for up to 5.7M shares.
- Gross proceeds of ~$6.4M before fees; closed May 9, 2024; proceeds for working capital and operations.
- Regains compliance with Nasdaq $2.5M stockholders' equity minimum after offering; subject to ongoing monitoring.
- Placement agent: Craig-Hallum; lock-up agreements for 90 days for executives and directors.

## SEC filing metadata
- accession: 0001104659-24-059372
- form_type: 8-K
- ticker: HSDT
- cik: 0001610853
- company_name: Solana Co
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610853/000110465924059372/0001104659-24-059372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610853/000110465924059372/tm2411553d9_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-059372
- JSON: https://secwatch.observer/filing/0001104659-24-059372.json
- Plain text: https://secwatch.observer/filing/0001104659-24-059372.txt

## Key facts
- Material Agreements
  Solana Co entered into Placement Agency Agreement with Craig-Hallum Capital Group LLC valued at approximately $6.4 million (effective 2024-05-06).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Craig-Hallum Capital Group LLC
  - Value: approximately $6.4 million
  - Effective: 2024-05-06
  source text: On May 6, 2024, Helius Medical Technologies, Inc., (the “Company”), entered into a placement agency agreement (the “Placement Agency Agreement”) with Craig-Hallum Capital Group LLC (the “Placement Agent”) for the purchase and sale, in a registered public offering by the Company (the “Public Offering”) of 704,999 shares of its Class A common stock, par value $0.001 per share (“Common Stock”) and 2,147,222 pre-funded warrants, each to purchase one share of Common Stock at an exercise price of $0.001 per share (the “Pre-funded Warrants”) together with accompanying Series A Warrants to purchase up to 2,852,221 shares of its Common Stock (“Series A Warrants”) and Series B Warrants to purchase up to 2,852,221 shares of its Common Stock (“Series B Warrants”, and together with the Series A Warrants, the “Public Warrants”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1610853/000110465924059372/0001104659-24-059372-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.